Electro-ophthalmological recovery after withdrawal from vigabatrin
暂无分享,去创建一个
[1] M. Marmor,et al. Standard for clinical electro-oculography , 1993, Documenta Ophthalmologica.
[2] Eberhart Zrenner,et al. Standard for clinical electroretinography (1994 update) , 2005, Documenta Ophthalmologica.
[3] G. Harding,et al. Visual electrophysiological effect of a GABA transaminase blocker , 1998, Documenta Ophthalmologica.
[4] C. V. van Veelen,et al. Long term changes in the visual fields of patients with temporal lobe epilepsy using vigabatrin , 2000, The British journal of ophthalmology.
[5] G. Harding,et al. Visual field defects associated with vigabatrin therapy , 1999, Journal of neurology, neurosurgery, and psychiatry.
[6] P. Derambure,et al. The relationship of MS to physical trauma and psychological stress: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. , 2000, Neurology.
[7] R. Beck. Vigabatrin-associated retinal cone system dysfunction , 1998, Neurology.
[8] M. Ruggieri,et al. Parental view of epilepsy in Angelman syndrome: a questionnaire study , 1998, Archives of disease in childhood.
[9] G. Krauss,et al. Vigabatrin-associated retinal cone system dysfunction , 1998, Neurology.
[10] A. Klistorner,et al. Severe persistent visual field constriction associated with vigabatrin. Asymptomatic as well as symptomatic defects occur with vigabatrin. , 1998, BMJ.
[11] T Eke,et al. Retrospective study of concussive convulsions in elite Australian rules and rugby league footballers: phenomenology, aetiology, and outcome , 1997, BMJ.
[12] E. Zrenner,et al. [Disorders of color perception and increase glare sensitivity in phenytoin and carbamazepine therapy. Ocular side effects of anticonvulsants]. , 1995, Der Nervenarzt.
[13] Michael F. Marmor,et al. Standard for clinical electrooculography , 1993 .
[14] M. Neal,et al. Immunocytochemical evidence that vigabatrin in rats causes GABA accumulation in glial cells of the retina , 1989, Neuroscience Letters.